A Phase I, Study of CDX-1140 a fully human agonist anti-CD40 monoclonal antibody as monotherapy or in combination in patients with advanced solid tumors

A Phase I, Study of CDX-1140 a fully human agonist anti-CD40 monoclonal antibody as monotherapy or in combination in patients with advanced solid tumors

Trial Category:
Head and Neck
Phase
I
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members